News Home

Should Biotechnology Stock Gossamer Bio Inc (GOSS) Be in Your Portfolio Friday?

Friday, March 01, 2024 12:40 PM | InvestorsObserver Analysts

Mentioned in this article

Should Biotechnology Stock Gossamer Bio Inc (GOSS) Be in Your Portfolio Friday?

Gossamer Bio Inc (GOSS) is near the top in its industry group according to InvestorsObserver. GOSS gets an overall rating of 74. That means it scores higher than 74 percent of stocks. Gossamer Bio Inc gets a 87 rank in the Biotechnology industry. Biotechnology is number 15 out of 148 industries.

Overall Score - 74
GOSS has an Overall Score of 74. Find out what this means to you and get the rest of the rankings on GOSS!

What do These Ratings Mean?

Searching for the best stocks to invest in can be difficult. There are thousands of options and it can be confusing on what actually constitutes a great value. InvestorsObserver allows you to choose from eight unique metrics to view the top industries and the best performing stocks in that industry. A score of 74 would rank higher than 74 percent of all stocks.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Gossamer Bio Inc Stock Today?

Gossamer Bio Inc (GOSS) stock is lower by -3.19% while the S&P 500 has risen 0.56% as of 12:39 PM on Friday, Mar 1. GOSS is lower by -$0.04 from the previous closing price of $1.41 on volume of 975,025 shares. Over the past year the S&P 500 is up 28.72% while GOSS is lower by -22.16%. GOSS lost -$1.76 per share the over the last 12 months. Click Here to get the full Stock Report for Gossamer Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App